| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | IQSEC3 DENND4A RAPGEF6 SGSM1 MYCBP2 MYO9A STXBP5L IQSEC2 OBSCN PSD3 ALS2 CHML ANKRD27 PREX2 RGS16 TBC1D4 RAB3IL1 ARHGAP21 | 3.61e-09 | 507 | 127 | 18 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | IQSEC3 DENND4A RAPGEF6 SGSM1 MYCBP2 MYO9A STXBP5L IQSEC2 OBSCN PSD3 ALS2 CHML ANKRD27 PREX2 RGS16 TBC1D4 RAB3IL1 ARHGAP21 | 3.61e-09 | 507 | 127 | 18 | GO:0030695 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | IQSEC3 DENND4A RAPGEF6 MYCBP2 IQSEC2 OBSCN PSD3 ALS2 ANKRD27 PREX2 RAB3IL1 | 2.68e-07 | 231 | 127 | 11 | GO:0005085 |
| GeneOntologyMolecularFunction | GTPase activator activity | SGSM1 MYO9A STXBP5L ALS2 CHML ANKRD27 PREX2 RGS16 TBC1D4 ARHGAP21 | 1.20e-05 | 279 | 127 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | enzyme regulator activity | IQSEC3 DENND4A RAPGEF6 SGSM1 MYCBP2 MYO9A STXBP5L IQSEC2 OBSCN PSD3 ALS2 CHML WNK1 ANKRD27 PREX2 RGS16 TBC1D4 EGFR SH3PXD2A EIF2AK2 RAB3IL1 ARHGAP21 | 8.29e-05 | 1418 | 127 | 22 | GO:0030234 |
| GeneOntologyMolecularFunction | enzyme activator activity | SGSM1 MYO9A STXBP5L ALS2 CHML WNK1 ANKRD27 PREX2 RGS16 TBC1D4 EGFR SH3PXD2A ARHGAP21 | 2.83e-04 | 656 | 127 | 13 | GO:0008047 |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.09e-04 | 51 | 127 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 4.14e-04 | 55 | 127 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 5.78e-04 | 60 | 127 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.48e-04 | 118 | 127 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.03e-03 | 70 | 127 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 1.40e-03 | 9 | 127 | 2 | GO:0036408 | |
| GeneOntologyCellularComponent | chromatin | TBX15 FOXR1 KDM5C SOX30 KAT6A HLX E2F3 RUNX3 JMJD1C MEF2C MEOX2 SP8 CSRNP3 HOXD13 FANCI NCOA1 ANKRD17 SP9 NR3C2 TAF1 MORC3 KAT6B | 1.14e-04 | 1480 | 130 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 2.44e-04 | 49 | 130 | 4 | GO:0099092 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 4.08e-04 | 56 | 130 | 4 | GO:0099091 | |
| HumanPheno | Deeply set eye | TBX15 KDM5C IQSEC2 KAT6A TOGARAM1 WDR26 MEF2C ASXL3 ANKRD17 CACNA1G TAF1 CAMTA1 | 8.18e-06 | 266 | 51 | 12 | HP:0000490 |
| HumanPheno | Upslanted palpebral fissure | RAD51C KDM5C IQSEC2 HECTD4 WDR26 JMJD1C MEF2C FANCI ASXL3 BUB1B ASPM ANKRD17 CACNA1G | 1.55e-05 | 333 | 51 | 13 | HP:0000582 |
| HumanPheno | Abnormal palate morphology | TBX15 RAD51C DLG5 LRP12 MYO9A KDM5C IQSEC2 APC2 KAT6A HECTD4 TOGARAM1 WDR26 JMJD1C CHUK USF3 HOXD13 FANCI ASXL3 BUB1B ASPM ANKRD17 TAF1 CAMTA1 KAT6B TET3 | 6.20e-05 | 1202 | 51 | 25 | HP:0000174 |
| HumanPheno | Protruding coccyx | 9.83e-05 | 2 | 51 | 2 | HP:0040017 | |
| HumanPheno | Enlarged proximal interphalangeal joints | 9.83e-05 | 2 | 51 | 2 | HP:0006185 | |
| HumanPheno | Prominent protruding coccyx | 9.83e-05 | 2 | 51 | 2 | HP:0008472 | |
| Domain | IQ | 6.32e-06 | 71 | 120 | 6 | PF00612 | |
| Domain | PH | PHLDB3 IQSEC3 KIF1B IQSEC2 OBSCN PSD3 ALS2 PREX2 PLEKHM1 ARHGAP21 | 1.25e-05 | 278 | 120 | 10 | SM00233 |
| Domain | PH_DOMAIN | PHLDB3 IQSEC3 KIF1B IQSEC2 OBSCN PSD3 ALS2 PREX2 PLEKHM1 ARHGAP21 | 1.29e-05 | 279 | 120 | 10 | PS50003 |
| Domain | PH_domain | PHLDB3 IQSEC3 KIF1B IQSEC2 OBSCN PSD3 ALS2 PREX2 PLEKHM1 ARHGAP21 | 1.33e-05 | 280 | 120 | 10 | IPR001849 |
| Domain | PH_dom-like | PHLDB3 IQSEC3 KIF1B IQSEC2 OBSCN PSD3 ALS2 WDFY4 PREX2 PLEKHM1 TBC1D4 ARHGAP21 | 1.94e-05 | 426 | 120 | 12 | IPR011993 |
| Domain | IQ_motif_EF-hand-BS | 2.49e-05 | 90 | 120 | 6 | IPR000048 | |
| Domain | IQ | 3.00e-05 | 93 | 120 | 6 | PS50096 | |
| Domain | - | PHLDB3 IQSEC3 KIF1B IQSEC2 OBSCN PSD3 ALS2 PREX2 PLEKHM1 TBC1D4 ARHGAP21 | 4.44e-05 | 391 | 120 | 11 | 2.30.29.30 |
| Domain | - | 1.11e-04 | 15 | 120 | 3 | 1.10.1000.11 | |
| Domain | Sec7 | 1.11e-04 | 15 | 120 | 3 | PF01369 | |
| Domain | Sec7_alpha_orthog | 1.11e-04 | 15 | 120 | 3 | IPR023394 | |
| Domain | IQSEC_PH | 1.22e-04 | 3 | 120 | 2 | IPR033742 | |
| Domain | IQ_SEC7_PH | 1.22e-04 | 3 | 120 | 2 | PF16453 | |
| Domain | SEC7 | 1.36e-04 | 16 | 120 | 3 | PS50190 | |
| Domain | Sec7 | 1.36e-04 | 16 | 120 | 3 | SM00222 | |
| Domain | Sec7_dom | 1.36e-04 | 16 | 120 | 3 | IPR000904 | |
| Domain | - | 1.80e-04 | 44 | 120 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 1.80e-04 | 44 | 120 | 4 | PF00225 | |
| Domain | KISc | 1.80e-04 | 44 | 120 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.80e-04 | 44 | 120 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.80e-04 | 44 | 120 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.80e-04 | 44 | 120 | 4 | PS50067 | |
| Domain | HAT_MYST-type | 4.04e-04 | 5 | 120 | 2 | IPR002717 | |
| Domain | MOZ_SAS | 4.04e-04 | 5 | 120 | 2 | PF01853 | |
| Domain | MYST_HAT | 4.04e-04 | 5 | 120 | 2 | PS51726 | |
| Domain | Man6P_isomerase_rcpt-bd_dom | 1.12e-03 | 8 | 120 | 2 | IPR009011 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 1.26e-05 | 90 | 81 | 6 | M27779 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 1.35e-05 | 91 | 81 | 6 | MM15518 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | DENND4A KIF26B KIF1B ALS2 TRAPPC8 CHML ANKRD27 KIF20A IGLV1-47 IGLV1-44 TBC1D4 EGFR IGKV3D-20 RAB3IL1 | 5.89e-05 | 725 | 81 | 14 | M27507 |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 5.89e-05 | 118 | 81 | 6 | MM15589 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 7.10e-05 | 122 | 81 | 6 | M27872 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG DLG5 DENND4A RAPGEF6 UBAP2 MYCBP2 MYO9A KIF26B KIF1B IQSEC2 PSD3 ALS2 WNK1 WDR26 ANKRD27 IVNS1ABP TBC1D4 INA SH3PXD2A STARD9 N4BP2 BUB1B ANKRD17 NR3C2 TANC1 MORC3 HECTD1 ARHGAP21 | 2.13e-18 | 861 | 132 | 28 | 36931259 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | DLG5 RAPGEF6 UBAP2 KIF26B NUP214 JMJD1C KIF20A EGFR BUB1B ASPM ANKRD17 TANC1 | 3.12e-10 | 256 | 132 | 12 | 33397691 |
| Pubmed | SYNRG DLG5 DENND4A RAPGEF6 MYO9A KIF26B TBC1D4 TANC1 TRAK2 HECTD1 ARHGAP21 | 5.20e-10 | 209 | 132 | 11 | 36779422 | |
| Pubmed | CNTN4 TOGARAM1 TRAPPC8 WNK1 WDFY4 JMJD1C SHROOM4 CEP68 USF3 ZBTB39 N4BP2 ELAPOR1 MORC3 HECTD1 MAML3 | 7.18e-10 | 493 | 132 | 15 | 15368895 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SGSM1 MYCBP2 MYO9A STXBP5L KIF1B KAT6A HECTD4 OBSCN E2F3 JMJD1C PLEKHM1 SENP1 USF3 TBC1D4 EGFR SH3PXD2A ANKRD17 TANC1 CAMTA1 KAT6B HECTD1 TET3 MAML3 | 9.65e-09 | 1489 | 132 | 23 | 28611215 |
| Pubmed | 2.15e-07 | 225 | 132 | 9 | 12168954 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG DLG5 OTUD5 MYO9A KDM5C KIF1B E2F3 WNK1 TBC1D4 N4BP2 ASPM TANC1 MORC3 | 4.16e-07 | 588 | 132 | 13 | 38580884 |
| Pubmed | IQSEC3 KIF1B PSD3 ALS2 NUP214 RNF157 STARD9 TRAK2 CAMTA1 TET3 ARHGAP21 | 4.81e-07 | 407 | 132 | 11 | 12693553 | |
| Pubmed | RAPGEF6 MYCBP2 NUP214 WDR26 JMJD1C TBC1D4 N4BP2 BUB1B ANKRD17 TAF1 ARHGAP21 | 6.25e-07 | 418 | 132 | 11 | 34709266 | |
| Pubmed | DLG5 UBAP2 KDM5C MTSS1 HECTD4 E2F3 ANKRD27 IVNS1ABP CAPRIN2 ANKRD17 CACNA1G KAT6B | 9.06e-07 | 529 | 132 | 12 | 14621295 | |
| Pubmed | 1.64e-06 | 52 | 132 | 5 | 9455477 | ||
| Pubmed | 2.61e-06 | 57 | 132 | 5 | 18022353 | ||
| Pubmed | 3.15e-06 | 105 | 132 | 6 | 9628581 | ||
| Pubmed | MYBPH DENND4A MYCBP2 KIF1B OBSCN WNK1 JMJD1C IVNS1ABP TBC1D4 TAF1 ARHGAP21 | 3.33e-06 | 497 | 132 | 11 | 23414517 | |
| Pubmed | 6.30e-06 | 255 | 132 | 8 | 15324660 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX15 FOXR1 SOX30 HLX E2F3 RUNX3 MEF2C MEOX2 USF3 HOXD13 NCOA1 SP9 NR3C2 CAMTA1 | 9.81e-06 | 908 | 132 | 14 | 19274049 |
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 1.19e-05 | 37 | 132 | 4 | 11416179 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26203193 | ||
| Pubmed | Interaction between mineralocorticoid receptor and epidermal growth factor receptor signaling. | 1.43e-05 | 2 | 132 | 2 | 21827828 | |
| Pubmed | Disruptions of the novel KIAA1202 gene are associated with X-linked mental retardation. | 1.43e-05 | 2 | 132 | 2 | 16249884 | |
| Pubmed | EGFR-mediated epidermal stem cell motility drives skin regeneration through COL17A1 proteolysis. | 1.43e-05 | 2 | 132 | 2 | 34550317 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17311890 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 39505971 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24150941 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 33994852 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15665285 | ||
| Pubmed | OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1. | 1.43e-05 | 2 | 132 | 2 | 38658981 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15197169 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27185879 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10648614 | ||
| Pubmed | DLG5 MYO9A KIF1B PSD3 NUP214 JMJD1C SLC38A1 EGFR FANCI BUB1B ANKRD17 ARHGAP21 | 1.74e-05 | 708 | 132 | 12 | 39231216 | |
| Pubmed | CNTN4 IQSEC3 UBAP2 MYCBP2 IQSEC2 APC2 HECTD4 WDR26 SENP1 INA N4BP2 ANKRD17 ZFR ARHGAP21 | 1.89e-05 | 963 | 132 | 14 | 28671696 | |
| Pubmed | 1.98e-05 | 42 | 132 | 4 | 23444366 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PHLDB3 SYNRG RAPGEF6 MYCBP2 KAT6A HECTD4 OBSCN NUP214 WNK1 PLEKHM1 RGS16 FANCI TANC1 HECTD1 ARHGAP21 | 2.08e-05 | 1105 | 132 | 15 | 35748872 |
| Pubmed | 3.13e-05 | 415 | 132 | 9 | 16385451 | ||
| Pubmed | TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease. | 4.28e-05 | 3 | 132 | 2 | 30357366 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 26202421 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 23243425 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 18728014 | ||
| Pubmed | Structural basis for binding of accessory proteins by the appendage domain of GGAs. | 4.28e-05 | 3 | 132 | 2 | 12858163 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 23708190 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 23063713 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 28390157 | ||
| Pubmed | MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain. | 4.28e-05 | 3 | 132 | 2 | 36754959 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 29339538 | ||
| Pubmed | The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. | 4.28e-05 | 3 | 132 | 2 | 20458145 | |
| Pubmed | The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-kappaB activation. | 4.28e-05 | 3 | 132 | 2 | 11313968 | |
| Pubmed | IKKalpha is required to maintain skin homeostasis and prevent skin cancer. | 4.28e-05 | 3 | 132 | 2 | 18772111 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 26059843 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 4.58e-05 | 544 | 132 | 10 | 28473536 | |
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 4.95e-05 | 19 | 132 | 3 | 30674481 | |
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 37059107 | ||
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 20937822 | ||
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 10935545 | ||
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 10848580 | ||
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 21880731 | ||
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 17591929 | ||
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 17980166 | ||
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 23455325 | ||
| Pubmed | The EGF receptor is required for efficient liver regeneration. | 8.54e-05 | 4 | 132 | 2 | 17940036 | |
| Pubmed | WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1. | 8.54e-05 | 4 | 132 | 2 | 31816312 | |
| Pubmed | RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status. | 8.54e-05 | 4 | 132 | 2 | 22729835 | |
| Pubmed | 8.54e-05 | 4 | 132 | 2 | 9073066 | ||
| Pubmed | 1.05e-04 | 486 | 132 | 9 | 20936779 | ||
| Pubmed | Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. | 1.42e-04 | 5 | 132 | 2 | 19165918 | |
| Pubmed | Binding partners for the COOH-terminal appendage domains of the GGAs and gamma-adaptin. | 1.42e-04 | 5 | 132 | 2 | 12808037 | |
| Pubmed | 1.42e-04 | 5 | 132 | 2 | 15358670 | ||
| Pubmed | Essential role for epidermal growth factor receptor in glutamate receptor signaling to NF-kappaB. | 1.42e-04 | 5 | 132 | 2 | 18541671 | |
| Pubmed | 1.42e-04 | 5 | 132 | 2 | 17182677 | ||
| Pubmed | MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. | 1.42e-04 | 5 | 132 | 2 | 11965546 | |
| Pubmed | The retinoblastoma tumor suppressor regulates a xenobiotic detoxification pathway. | 1.42e-04 | 5 | 132 | 2 | 22022495 | |
| Pubmed | Src-mediated RGS16 tyrosine phosphorylation promotes RGS16 stability. | 1.42e-04 | 5 | 132 | 2 | 12588871 | |
| Pubmed | 1.42e-04 | 5 | 132 | 2 | 25066130 | ||
| Pubmed | 1.42e-04 | 5 | 132 | 2 | 23153538 | ||
| Pubmed | A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR. | 1.42e-04 | 5 | 132 | 2 | 17353003 | |
| Pubmed | 1.46e-04 | 27 | 132 | 3 | 19026994 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SYNRG RAPGEF6 MYCBP2 OTUD5 KDM5C KIF1B NUP214 TBC1D4 EGFR ANKRD17 KAT6B | 1.87e-04 | 774 | 132 | 11 | 15302935 |
| Pubmed | MEF2B is a potent transactivator expressed in early myogenic lineages. | 2.12e-04 | 6 | 132 | 2 | 8668199 | |
| Pubmed | 2.12e-04 | 6 | 132 | 2 | 20181743 | ||
| Pubmed | Steroid receptor coactivator-2 is a dual regulator of cardiac transcription factor function. | 2.12e-04 | 6 | 132 | 2 | 24811170 | |
| Pubmed | Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection. | 2.12e-04 | 6 | 132 | 2 | 19797524 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.48e-04 | 430 | 132 | 8 | 35044719 | |
| Pubmed | 2.75e-04 | 233 | 132 | 6 | 37704626 | ||
| Pubmed | 2.97e-04 | 7 | 132 | 2 | 34343497 | ||
| Pubmed | 2.97e-04 | 7 | 132 | 2 | 15669143 | ||
| Pubmed | Physical and functional link of the leukemia-associated factors AML1 and PML. | 2.97e-04 | 7 | 132 | 2 | 15331439 | |
| Pubmed | Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. | 2.97e-04 | 7 | 132 | 2 | 18794358 | |
| Pubmed | RGS16 function is regulated by epidermal growth factor receptor-mediated tyrosine phosphorylation. | 2.97e-04 | 7 | 132 | 2 | 11602604 | |
| Pubmed | 2.97e-04 | 7 | 132 | 2 | 9721103 | ||
| Pubmed | 3.05e-04 | 153 | 132 | 5 | 10718198 | ||
| Pubmed | 3.36e-04 | 242 | 132 | 6 | 34011540 | ||
| Pubmed | CNTN4 MYCBP2 KIF1B IQSEC2 APC2 HECTD4 E2F3 WDR26 CHUK MIGA1 TAF1 MORC3 HECTD1 ARHGAP21 | 3.90e-04 | 1285 | 132 | 14 | 35914814 | |
| Pubmed | Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. | 3.94e-04 | 8 | 132 | 2 | 11971985 | |
| Pubmed | 4.09e-04 | 38 | 132 | 3 | 23273568 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 4.76e-04 | 361 | 132 | 7 | 26167880 | |
| Pubmed | ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking. | 5.06e-04 | 9 | 132 | 2 | 21275903 | |
| Pubmed | 5.06e-04 | 9 | 132 | 2 | 17509151 | ||
| Pubmed | Identification of genetic variants associated with response to statin therapy. | 5.06e-04 | 9 | 132 | 2 | 19667110 | |
| Pubmed | Key pathways regulated by HoxA9,10,11/HoxD9,10,11 during limb development. | 5.06e-04 | 9 | 132 | 2 | 26186931 | |
| Pubmed | Hurp deficiency in mice leads to female infertility caused by an implantation defect. | 5.06e-04 | 9 | 132 | 2 | 18676373 | |
| Interaction | YWHAH interactions | SYNRG DLG5 DENND4A RAPGEF6 UBAP2 MYCBP2 MYO9A KIF26B KIF1B IQSEC2 HECTD4 PSD3 ALS2 WNK1 WDR26 ANKRD27 IVNS1ABP TBC1D4 INA SH3PXD2A STARD9 NCOA1 ANKRD17 NR3C2 TANC1 MORC3 HECTD1 ARHGAP21 | 2.26e-10 | 1102 | 128 | 28 | int:YWHAH |
| Interaction | YWHAB interactions | SYNRG DLG5 DENND4A RAPGEF6 MYCBP2 MYO9A KIF26B KIF1B IQSEC2 KAT6A HECTD4 PSD3 ALS2 TRAPPC8 WNK1 IVNS1ABP TBC1D4 EGFR SH3PXD2A STARD9 ANKRD17 TANC1 MORC3 HECTD1 VWA2 ARHGAP21 | 9.26e-10 | 1014 | 128 | 26 | int:YWHAB |
| Interaction | YWHAZ interactions | SYNRG DLG5 DENND4A RAPGEF6 MYCBP2 MYO9A KIF26B KIF1B IQSEC2 KAT6A HECTD4 PSD3 ALS2 WNK1 ANKRD27 MEF2C IVNS1ABP TBC1D4 INA EGFR SH3PXD2A STARD9 ASXL3 ANKRD17 TANC1 MORC3 HECTD1 VWA2 ARHGAP21 | 2.88e-09 | 1319 | 128 | 29 | int:YWHAZ |
| Interaction | YWHAQ interactions | SYNRG DLG5 DENND4A RAPGEF6 UBAP2 MYCBP2 MYO9A KIF26B KIF1B IQSEC2 HECTD4 PSD3 ALS2 WNK1 IVNS1ABP TBC1D4 INA EGFR SH3PXD2A STARD9 NCOA1 ANKRD17 TANC1 HECTD1 VWA2 ARHGAP21 | 7.11e-09 | 1118 | 128 | 26 | int:YWHAQ |
| Interaction | PHLPP1 interactions | DLG5 RAPGEF6 UBAP2 KIF26B NUP214 JMJD1C KIF20A EGFR FANCI BUB1B ASPM ANKRD17 TANC1 | 2.08e-07 | 333 | 128 | 13 | int:PHLPP1 |
| Interaction | YWHAG interactions | SYNRG DLG5 DENND4A RAPGEF6 UBAP2 MYCBP2 MYO9A KIF26B KIF1B IQSEC2 HECTD4 PSD3 ALS2 WNK1 TBC1D4 INA SH3PXD2A STARD9 N4BP2 ANKRD17 TANC1 MORC3 HECTD1 ARHGAP21 | 9.74e-07 | 1248 | 128 | 24 | int:YWHAG |
| Interaction | SFN interactions | SYNRG DENND4A RAPGEF6 MYCBP2 MYO9A KIF26B KIF1B WNK1 WDR26 TBC1D4 INA EGFR SH3PXD2A ANKRD17 TANC1 HECTD1 ARHGAP21 | 1.86e-06 | 692 | 128 | 17 | int:SFN |
| Interaction | YWHAE interactions | SYNRG DLG5 DENND4A RAPGEF6 MYCBP2 MYO9A KIF26B KIF1B IQSEC2 PSD3 ALS2 WNK1 ANKRD27 IVNS1ABP TBC1D4 INA SH3PXD2A ANKRD17 TANC1 MORC3 HECTD1 ARHGAP21 | 1.31e-05 | 1256 | 128 | 22 | int:YWHAE |
| Interaction | SLC13A4 interactions | 3.74e-05 | 30 | 128 | 4 | int:SLC13A4 | |
| Interaction | MEAF6 interactions | 5.32e-05 | 104 | 128 | 6 | int:MEAF6 | |
| Interaction | PHF21A interactions | PHLDB3 RAPGEF6 MYCBP2 NUP214 WDR26 JMJD1C TBC1D4 BUB1B TAF1 ARHGAP21 | 6.87e-05 | 343 | 128 | 10 | int:PHF21A |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.30e-06 | 17 | 90 | 4 | 486 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 7.98e-05 | 46 | 90 | 4 | 622 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 8.62e-04 | 9 | 90 | 2 | 755 | |
| GeneFamily | PDZ domain containing | 9.73e-04 | 152 | 90 | 5 | 1220 | |
| GeneFamily | VPS9 domain containing | 1.07e-03 | 10 | 90 | 2 | 928 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.26e-03 | 161 | 90 | 5 | 593 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 2.81e-03 | 16 | 90 | 2 | 66 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.67e-03 | 206 | 90 | 5 | 682 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.35e-03 | 66 | 90 | 3 | 722 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.39e-03 | 20 | 90 | 2 | 548 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 4.51e-03 | 134 | 90 | 4 | 861 | |
| GeneFamily | CD molecules|Mucins | 4.84e-03 | 21 | 90 | 2 | 648 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 6.30e-03 | 24 | 90 | 2 | 485 | |
| GeneFamily | Fibronectin type III domain containing | 8.37e-03 | 160 | 90 | 4 | 555 | |
| Coexpression | GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN | 8.20e-06 | 200 | 132 | 8 | M9791 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 2.18e-05 | 166 | 132 | 7 | M7009 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN | 2.64e-05 | 171 | 132 | 7 | M6321 | |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 2.64e-05 | 171 | 132 | 7 | M2947 | |
| Coexpression | GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP | 3.80e-05 | 181 | 132 | 7 | M6857 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | TBX15 LRP12 DENND4A COL17A1 KIF26B KDM5C KIF1B PSD3 RUNX3 SP8 CSRNP3 EGFR HOXD13 STARD9 ASXL3 CAMTA1 KAT6B VWA2 | 4.40e-06 | 850 | 130 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | IQSEC3 SGSM1 STXBP5L KIF1B APC2 SQLE PSD3 RUNX3 CHML RGS16 MEOX2 SLC38A1 SP8 INA CSRNP3 ELAPOR1 ASPM NCOA1 SP9 | 8.99e-06 | 986 | 130 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_200 | 9.72e-06 | 169 | 130 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CNTN4 COL17A1 MYCBP2 KIF26B KDM5C KIF1B NUP214 WNK1 WDR26 SP8 ZBTB39 INA HOXD13 VNN1 ASXL3 MIGA1 KAT6B | 1.06e-05 | 818 | 130 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#4_top-relative-expression-ranked_100 | 2.61e-05 | 10 | 130 | 3 | gudmap_developingLowerUrinaryTract_adult_ureter_100_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | TBX15 DLG5 IQSEC3 DENND4A COL17A1 PPDPF KIF26B SH3PXD2A STARD9 ASXL3 CACNA1G NR3C2 EIF2AK2 | 6.80e-05 | 589 | 130 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | TBX15 DLG5 IQSEC3 DENND4A COL17A1 PPDPF KIF26B HECTD4 SH3PXD2A STARD9 CACNA1G NR3C2 EIF2AK2 | 9.20e-05 | 607 | 130 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | SYNRG DENND4A SGSM1 STXBP5L KIF1B APC2 SQLE PSD3 RUNX3 CHML RGS16 RNF157 CSRNP3 ASPM NCOA1 SP9 | 1.15e-04 | 893 | 130 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | RAD51C COL17A1 MYCBP2 KIF26B KIF1B NUP214 SP8 ZBTB39 INA CSRNP3 EGFR HOXD13 ASPM ADAMTS18 MIGA1 | 1.26e-04 | 806 | 130 | 15 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | TBX15 DLG5 IQSEC3 DENND4A COL17A1 PPDPF KIF26B SH3PXD2A STARD9 ASXL3 CACNA1G NR3C2 EIF2AK2 | 1.60e-04 | 642 | 130 | 13 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_100 | 1.76e-04 | 85 | 130 | 5 | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | RAPGEF6 MYCBP2 KAT6A TOGARAM1 TRAPPC8 WNK1 JMJD1C SHQ1 KLHL5 ANKRD17 HECTD1 MAML3 | 1.84e-04 | 564 | 130 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TBX15 DLG5 IQSEC3 DENND4A COL17A1 PPDPF KIF26B PREX2 SH3PXD2A STARD9 ASXL3 CACNA1G NR3C2 EIF2AK2 | 1.91e-04 | 744 | 130 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | TBX15 DLG5 IQSEC3 DENND4A COL17A1 PPDPF KIF26B SH3PXD2A STARD9 CACNA1G NR3C2 EIF2AK2 | 1.93e-04 | 567 | 130 | 12 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | TBX15 DLG5 IQSEC3 DENND4A COL17A1 PPDPF KIF26B HECTD4 SH3PXD2A STARD9 CACNA1G NR3C2 EIF2AK2 | 1.95e-04 | 655 | 130 | 13 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 2.42e-04 | 496 | 130 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.46e-04 | 339 | 130 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_100 | 2.56e-04 | 92 | 130 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | TBX15 CNTN4 IQSEC3 COL17A1 STXBP5L KIF26B APC2 PSD3 RUNX3 RNF157 MEOX2 EGFR ELAPOR1 NCOA1 CACNA1G NR3C2 | 2.82e-04 | 967 | 130 | 16 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | TBX15 LRP12 COL17A1 KIF26B RUNX3 SP8 CSRNP3 EGFR HOXD13 CAMTA1 | 3.09e-04 | 428 | 130 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | RAD51C FOXR1 BTBD10 ALS2 TRAPPC8 TEX11 PLEKHM1 SHQ1 KIF20A INA FANCI CAPRIN2 BUB1B MORC3 | 3.73e-04 | 795 | 130 | 14 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SYNRG DENND4A STXBP5L APC2 SQLE HECTD4 PSD3 RUNX3 RGS16 RNF157 CSRNP3 NCOA1 | 3.97e-04 | 614 | 130 | 12 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | COL17A1 MYCBP2 KIF26B KDM5C KIF1B NUP214 WDR26 SP8 ZBTB39 EGFR HOXD13 ADAMTS18 CAMTA1 EIF2AK2 | 4.28e-04 | 806 | 130 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_200 | 4.61e-04 | 160 | 130 | 6 | gudmap_developingKidney_e11.5_metaneph mesench_200 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | SYNRG DENND4A STXBP5L APC2 SQLE HECTD4 PSD3 RUNX3 RGS16 RNF157 CSRNP3 NCOA1 KAT6B | 4.88e-04 | 721 | 130 | 13 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 4.92e-04 | 162 | 130 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_500 | 5.34e-04 | 61 | 130 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 5.42e-04 | 165 | 130 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | SYNRG DENND4A STXBP5L APC2 SQLE HECTD4 PSD3 RUNX3 RGS16 RNF157 CSRNP3 NCOA1 KAT6B | 5.48e-04 | 730 | 130 | 13 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | TBX15 DLG5 IQSEC3 DENND4A COL17A1 PPDPF KIF26B SH3PXD2A STARD9 ASXL3 CACNA1G NR3C2 EIF2AK2 | 5.55e-04 | 731 | 130 | 13 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG DENND4A STXBP5L APC2 SQLE HECTD4 PSD3 RUNX3 RGS16 RNF157 CSRNP3 STARD9 NCOA1 | 5.63e-04 | 732 | 130 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | TBX15 DLG5 IQSEC3 DENND4A COL17A1 PPDPF KIF26B SH3PXD2A STARD9 ASXL3 CACNA1G NR3C2 EIF2AK2 | 5.77e-04 | 734 | 130 | 13 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TBX15 LRP12 DENND4A COL17A1 KIF26B PSD3 TOGARAM1 RUNX3 SP8 CSRNP3 EGFR HOXD13 ZFR KAT6B | 6.14e-04 | 836 | 130 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | 6.18e-04 | 385 | 130 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_200 | 6.57e-04 | 28 | 130 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | TBX15 DLG5 IQSEC3 DENND4A COL17A1 PPDPF KIF26B SH3PXD2A STARD9 CACNA1G NR3C2 EIF2AK2 | 6.76e-04 | 652 | 130 | 12 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | TBX15 LRP12 DENND4A KIF26B KIF1B PSD3 CSRNP3 EGFR STARD9 VWA2 | 7.30e-04 | 478 | 130 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG DENND4A STXBP5L APC2 SQLE HECTD4 PSD3 RUNX3 RGS16 RNF157 CSRNP3 NCOA1 | 7.32e-04 | 658 | 130 | 12 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_200 | 7.38e-04 | 175 | 130 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | SYNRG DENND4A STXBP5L APC2 SQLE HECTD4 PSD3 RUNX3 RGS16 RNF157 CSRNP3 NCOA1 | 7.42e-04 | 659 | 130 | 12 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_500 | 7.63e-04 | 67 | 130 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 8.52e-04 | 69 | 130 | 4 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.71e-04 | 249 | 130 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | B cells, B1a.PC, IgD+ IgM+ CD19+ CD43+ CD5+ CD45R+, Peritoneal Cavity, avg-3 | 8.92e-04 | 325 | 130 | 8 | GSM538222_500 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 6.28e-09 | 192 | 132 | 9 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-08 | 183 | 132 | 8 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 1.07e-07 | 191 | 132 | 8 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 1.16e-07 | 193 | 132 | 8 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.16e-07 | 193 | 132 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.36e-06 | 185 | 132 | 7 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-06 | 189 | 132 | 7 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 1.74e-06 | 192 | 132 | 7 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-06 | 196 | 132 | 7 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-06 | 199 | 132 | 7 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Basal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.20e-06 | 199 | 132 | 7 | 6a274a5db02c55bbf31d602b9d5c8394241acdca | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.28e-06 | 200 | 132 | 7 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Aqp5_Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.27e-06 | 136 | 132 | 6 | 8f5682422ba0b477c1e0700212948457f106cb10 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 148 | 132 | 6 | bbf4933582b50b3412c805de5ed137107c996236 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 148 | 132 | 6 | 6543860e3207a7de92a35bb6004be51287582f7a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 148 | 132 | 6 | 79e376503a3f9504a1ec5af4a60a09cc80e19059 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.54e-06 | 149 | 132 | 6 | 5293c50b3fb41b1edaf9a97354899bd13770078c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-05 | 167 | 132 | 6 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 169 | 132 | 6 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.22e-05 | 171 | 132 | 6 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-05 | 174 | 132 | 6 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 174 | 132 | 6 | 6688424fc4e40c3c4a89669a2bc79369a726f1e6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 175 | 132 | 6 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 176 | 132 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 177 | 132 | 6 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 178 | 132 | 6 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 182 | 132 | 6 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-05 | 182 | 132 | 6 | d1c3cc2942faec7527a3c25869fd65c17899e5e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-05 | 182 | 132 | 6 | 92f83f29e358000cd86a709eb8b6199761ffe8bd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-05 | 182 | 132 | 6 | 02baca9a72c7b559c3e452693b3b134af804c868 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 1.79e-05 | 183 | 132 | 6 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-05 | 183 | 132 | 6 | 228092290dbb08785c4eda224e3ad03e99e10fab | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.84e-05 | 184 | 132 | 6 | 0a26bcc6610f756939e32a4d6dfeebcbf3a1db86 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.84e-05 | 184 | 132 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 2.02e-05 | 187 | 132 | 6 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 188 | 132 | 6 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-05 | 189 | 132 | 6 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-05 | 190 | 132 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.21e-05 | 190 | 132 | 6 | 58a6ab70737d719ca9725ac087f20dfe9be0463e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 191 | 132 | 6 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.34e-05 | 192 | 132 | 6 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 192 | 132 | 6 | 86d792682ba51696f503c79625dd20f87bcf651f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-05 | 192 | 132 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 192 | 132 | 6 | d0ad6a205ad50a3c523fa68676996b289eabc5de | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 192 | 132 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-05 | 192 | 132 | 6 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.41e-05 | 193 | 132 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.41e-05 | 193 | 132 | 6 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 2.41e-05 | 193 | 132 | 6 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.41e-05 | 193 | 132 | 6 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 194 | 132 | 6 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 194 | 132 | 6 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 2.48e-05 | 194 | 132 | 6 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.48e-05 | 194 | 132 | 6 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 194 | 132 | 6 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 194 | 132 | 6 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-05 | 194 | 132 | 6 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-05 | 195 | 132 | 6 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 195 | 132 | 6 | 2d485373bfd9bb4bb9236bf0b31d03e132c8018f | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-05 | 195 | 132 | 6 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 2.55e-05 | 195 | 132 | 6 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 195 | 132 | 6 | c14d730dd5c94247bc09711eaa5a53bd5a5957be | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-05 | 195 | 132 | 6 | 5812b1615676f3b77eb4769216b98b360c417c0d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 195 | 132 | 6 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.63e-05 | 196 | 132 | 6 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-05 | 197 | 132 | 6 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Plasma_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.70e-05 | 197 | 132 | 6 | 275f38ed7e477000e864cecf9b7d49ae134c3b6a | |
| ToppCell | T_cells-CCR7+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.70e-05 | 197 | 132 | 6 | 904430779c42b51d3eec62cf0cdd501b17058d8b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_3|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.70e-05 | 197 | 132 | 6 | d77bc37a77546a1f0a508486a38a45e571e4645b | |
| ToppCell | MS-IIF-Lymphocyte-B-Plasmablast|IIF / Disease, condition lineage and cell class | 2.70e-05 | 197 | 132 | 6 | 1b5ac53297cc557e08b9e8e511c2385a38f56bd6 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_basal-Dividing_Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 197 | 132 | 6 | 0a6754a5109bec0d0de42adbfdf4db43ff60c3d2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-05 | 197 | 132 | 6 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 2.78e-05 | 198 | 132 | 6 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.78e-05 | 198 | 132 | 6 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.78e-05 | 198 | 132 | 6 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 198 | 132 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 198 | 132 | 6 | 79c690d21d3420d0bb1a3b3b4ea2c9aa3810a219 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.78e-05 | 198 | 132 | 6 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 2.86e-05 | 199 | 132 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | mLN-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 2.86e-05 | 199 | 132 | 6 | c81a194f8c2f120c6c4d74857912865a3c2fe1e7 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.86e-05 | 199 | 132 | 6 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 2.86e-05 | 199 | 132 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-SPP1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.86e-05 | 199 | 132 | 6 | d94cf750599366061066074e8007d707adf6fc5a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-05 | 199 | 132 | 6 | 77b4aa00f14b86ef5db0490be98787e063979541 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | f3dc07a7cc8cf041da8fe610d21af595818cf2d8 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.94e-05 | 200 | 132 | 6 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | f100edfd2b3b742458cbbf34de9c403c4d272d3c | |
| ToppCell | mLN-T_cell-cycling_gd_T|mLN / Region, Cell class and subclass | 2.94e-05 | 200 | 132 | 6 | 4efeef51f885ee8f6dd3911a536cc49e3c14da98 | |
| ToppCell | mLN-(1)_T_cell-(18)_cycling_gd_T|mLN / shred on region, Cell_type, and subtype | 2.94e-05 | 200 | 132 | 6 | e8a0a88a8344e80783931115bbe6cd5b62a4c1f7 | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 200 | 132 | 6 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-05 | 200 | 132 | 6 | 0de9e7412a1725a8acd51820aa3135a112ced36c | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | fa1eaf008b54bdf7bbcdec8134460c5f64490de9 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 200 | 132 | 6 | 0bba93f1271dac704dddcdea8cb0f84a7ac6f42a | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | 83c4181c083b364f0d3a89ae7a0504781fa9fa9f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 200 | 132 | 6 | c9479452ab8c51139522383f745f02171ebbd7e2 | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | f15baf287ec467664c23faa53fdea45257f7b9d0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.15e-05 | 135 | 132 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.78e-06 | 197 | 128 | 9 | 6389_DN | |
| Disease | Intellectual Disability | IQSEC3 KDM5C APC2 E2F3 WDR26 MEF2C SHROOM4 CACNA1G TAF1 TET3 | 2.02e-05 | 447 | 124 | 10 | C3714756 |
| Disease | 1-methylurate measurement | 2.55e-05 | 14 | 124 | 3 | EFO_0021173 | |
| Disease | lymphocyte count | SYNRG HTR1D UBAP2 KIF1B HECTD4 PSD3 E2F3 NFS1 RUNX3 CHML JMJD1C PREX2 EGFR NR3C2 SIGLEC1 MORC3 MUC22 VWA2 | 4.12e-05 | 1464 | 124 | 18 | EFO_0004587 |
| Disease | hepatocellular carcinoma (is_marker_for) | 4.23e-05 | 301 | 124 | 8 | DOID:684 (is_marker_for) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.43e-05 | 222 | 124 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | N-acetyl-cadaverine measurement | 5.24e-05 | 3 | 124 | 2 | EFO_0800045 | |
| Disease | 4-acetamidobutanoate-to-N1-methyladenosine ratio | 5.24e-05 | 3 | 124 | 2 | EFO_0021418 | |
| Disease | X-12410 measurement | 5.24e-05 | 3 | 124 | 2 | EFO_0800715 | |
| Disease | monocyte percentage of leukocytes | DENND4A KIF1B IQSEC2 HLX WNK1 SLCO1B1 WDR26 JMJD1C MEF2C KLHL5 NCOA1 ACKR2 | 6.20e-05 | 731 | 124 | 12 | EFO_0007989 |
| Disease | neutrophil count | TBX15 DENND4A MYCBP2 KDM5C KIF1B IQSEC2 HECTD4 PSD3 HLX RUNX3 WDR26 JMJD1C PREX2 ELAPOR1 NCOA1 ACKR2 MUC22 | 6.84e-05 | 1382 | 124 | 17 | EFO_0004833 |
| Disease | electrocardiography | MYCBP2 OBSCN E2F3 JMJD1C SP8 SH3PXD2A ADAMTS18 CACNA1G NR3C2 KAT6B | 8.42e-05 | 530 | 124 | 10 | EFO_0004327 |
| Disease | response to anti-tuberculosis drug, tuberculosis, drug-induced liver injury | 1.05e-04 | 4 | 124 | 2 | EFO_0004228, EFO_0007918, MONDO_0018076 | |
| Disease | immature platelet fraction | 1.23e-04 | 114 | 124 | 5 | EFO_0009187 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.31e-04 | 264 | 124 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | Colorectal Carcinoma | CNTN4 APC2 OBSCN WNK1 PREX2 CSRNP3 EGFR BUB1B ADAMTS18 NR3C2 VWA2 | 1.90e-04 | 702 | 124 | 11 | C0009402 |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.04e-04 | 127 | 124 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.07e-04 | 200 | 124 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 2.08e-04 | 69 | 124 | 4 | EFO_0022341 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 2.87e-04 | 75 | 124 | 4 | EFO_0022287 | |
| Disease | platelet component distribution width | MTSS1 TEX11 WNK1 JMJD1C MEF2C CEP68 EGFR NR3C2 SIGLEC1 CAMTA1 SEC14L5 | 3.53e-04 | 755 | 124 | 11 | EFO_0007984 |
| Disease | smoking status measurement, inflammatory bowel disease | 3.63e-04 | 7 | 124 | 2 | EFO_0003767, EFO_0006527 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.89e-04 | 225 | 124 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | triacylglycerol 58:10 measurement | 3.94e-04 | 34 | 124 | 3 | EFO_0010437 | |
| Disease | triglyceride measurement, physical activity | 3.94e-04 | 34 | 124 | 3 | EFO_0003940, EFO_0004530 | |
| Disease | Inflammatory Bowel Diseases | 4.30e-04 | 35 | 124 | 3 | C0021390 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 4.40e-04 | 150 | 124 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 4.67e-04 | 36 | 124 | 3 | DOID:3907 (is_marker_for) | |
| Disease | Growth Disorders | 4.67e-04 | 36 | 124 | 3 | C0018273 | |
| Disease | sporadic amyotrophic lateral sclerosis, survival time | 4.82e-04 | 8 | 124 | 2 | EFO_0000714, EFO_0001357 | |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 4.82e-04 | 8 | 124 | 2 | DOID:4479 (is_implicated_in) | |
| Disease | fibrinogen measurement, coronary artery disease | 4.96e-04 | 154 | 124 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | fatty acid measurement | 5.28e-04 | 436 | 124 | 8 | EFO_0005110 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.34e-04 | 239 | 124 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | Malignant neoplasm of breast | RAD51C APC2 OBSCN NUP214 TRAPPC8 WNK1 SLCO1B1 INA EGFR N4BP2 ELAPOR1 NCOA1 KAT6B | 6.01e-04 | 1074 | 124 | 13 | C0006142 |
| Disease | advanced glycation end-product measurement | 6.19e-04 | 9 | 124 | 2 | EFO_0007819 | |
| Disease | 5-acetylamino-6-formylamino-3-methyluracil measurement | 6.19e-04 | 9 | 124 | 2 | EFO_0800950 | |
| Disease | level of Sphingomyelin (d36:1) in blood serum | 6.19e-04 | 9 | 124 | 2 | OBA_2045178 | |
| Disease | immunoglobulin M measurement | 6.19e-04 | 9 | 124 | 2 | EFO_0020466 | |
| Disease | high grade glioma (is_marker_for) | 7.38e-04 | 42 | 124 | 3 | DOID:3070 (is_marker_for) | |
| Disease | Pseudohypoaldosteronism, Type I | 7.71e-04 | 10 | 124 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 7.71e-04 | 10 | 124 | 2 | C0033805 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 7.71e-04 | 10 | 124 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 7.71e-04 | 10 | 124 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 7.71e-04 | 10 | 124 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 7.71e-04 | 10 | 124 | 2 | C1449842 | |
| Disease | cognitive function measurement, self reported educational attainment | 7.77e-04 | 355 | 124 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | cholesteryl ester measurement | 7.81e-04 | 257 | 124 | 6 | EFO_0010351 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 7.91e-04 | 43 | 124 | 3 | EFO_0022290 | |
| Disease | Autistic Disorder | 8.46e-04 | 261 | 124 | 6 | C0004352 | |
| Disease | alpha fetoprotein measurement | 8.53e-04 | 100 | 124 | 4 | EFO_0010583 | |
| Disease | Adenoid Cystic Carcinoma | 8.53e-04 | 100 | 124 | 4 | C0010606 | |
| Disease | 1-methylxanthine measurement | 9.40e-04 | 11 | 124 | 2 | EFO_0021174 | |
| Disease | 5-acetylamino-6-amino-3-methyluracil measurement | 9.40e-04 | 11 | 124 | 2 | EFO_0800951 | |
| Disease | cognitive function measurement | IL10RA CNTN4 DENND4A SGSM1 MTSS1 PSD3 POM121L2 SLCO1B1 JMJD1C MEF2C PLEKHM1 SLC38A1 ZFR MAML3 ARHGAP21 | 1.02e-03 | 1434 | 124 | 15 | EFO_0008354 |
| Disease | N-acetylputrescine measurement | 1.12e-03 | 12 | 124 | 2 | EFO_0800127 | |
| Disease | disks large homolog 3 measurement | 1.12e-03 | 12 | 124 | 2 | EFO_0802472 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.13e-03 | 276 | 124 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | Epilepsy | 1.18e-03 | 109 | 124 | 4 | C0014544 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 1.23e-03 | 50 | 124 | 3 | EFO_0022303 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.30e-03 | 51 | 124 | 3 | EFO_0022302 | |
| Disease | ovary epithelial cancer (is_marker_for) | 1.33e-03 | 13 | 124 | 2 | DOID:2152 (is_marker_for) | |
| Disease | N-acetylglutamine measurement | 1.33e-03 | 13 | 124 | 2 | EFO_0800017 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.33e-03 | 13 | 124 | 2 | EFO_0800474 | |
| Disease | monocyte count | DENND4A KIF1B HLX WNK1 SLCO1B1 MEF2C PREX2 PLEKHM1 KLHL5 EGFR NCOA1 ACKR2 MUC22 VWA2 | 1.33e-03 | 1320 | 124 | 14 | EFO_0005091 |
| Disease | free cholesterol to total lipids in small LDL percentage | 1.46e-03 | 53 | 124 | 3 | EFO_0022286 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.49e-03 | 197 | 124 | 5 | EFO_0005680 | |
| Disease | dystonia (is_implicated_in) | 1.54e-03 | 14 | 124 | 2 | DOID:543 (is_implicated_in) | |
| Disease | Fanconi anemia | 1.54e-03 | 14 | 124 | 2 | cv:C0015625 | |
| Disease | cortical surface area measurement | CCDC91 HTR1D MYCBP2 KIF26B KIF1B MEF2C PLEKHM1 SLC38A1 SP8 INA EGFR ADAMTS18 NR3C2 ARHGAP21 | 1.58e-03 | 1345 | 124 | 14 | EFO_0010736 |
| Disease | diet measurement | PPDPF KIF26B POM121L2 JMJD1C MEF2C PLEKHM1 SLC38A1 SP8 NR3C2 CAMTA1 MAML3 PCSK9 | 1.58e-03 | 1049 | 124 | 12 | EFO_0008111 |
| Disease | metabolic syndrome | 1.60e-03 | 200 | 124 | 5 | EFO_0000195 | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.62e-03 | 55 | 124 | 3 | EFO_0004623, HP_0002140 | |
| Disease | reticulocyte measurement | CCDC91 DENND4A UBAP2 HECTD4 RUNX3 SLCO1B1 JMJD1C SENP1 SIGLEC1 EIF2AK2 RAB3IL1 ARHGAP21 | 1.63e-03 | 1053 | 124 | 12 | EFO_0010700 |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 1.71e-03 | 56 | 124 | 3 | EFO_0022316 | |
| Disease | response to statin, LDL cholesterol change measurement | 1.77e-03 | 15 | 124 | 2 | EFO_0007804, GO_0036273 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 1.78e-03 | 122 | 124 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | fibrinogen measurement, factor VII measurement | 1.89e-03 | 58 | 124 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | triglycerides to total lipids in small LDL percentage | 1.98e-03 | 59 | 124 | 3 | EFO_0022337 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 1.98e-03 | 59 | 124 | 3 | EFO_0022260 | |
| Disease | 4-acetamidobutanoate measurement | 2.02e-03 | 16 | 124 | 2 | EFO_0021003 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 2.02e-03 | 16 | 124 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 2.02e-03 | 16 | 124 | 2 | OBA_2045195 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 2.08e-03 | 60 | 124 | 3 | EFO_0021898 | |
| Disease | vital capacity | CCDC91 TBX15 HLX POM121L2 WDR26 JMJD1C PLEKHM1 MEOX2 SENP1 CAPRIN2 ADAMTS18 NCOA1 MIGA1 | 2.13e-03 | 1236 | 124 | 13 | EFO_0004312 |
| Disease | Limb Deformities, Congenital | 2.29e-03 | 17 | 124 | 2 | C0206762 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 2.29e-03 | 62 | 124 | 3 | EFO_0022306 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 2.29e-03 | 62 | 124 | 3 | EFO_0022263 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 2.39e-03 | 63 | 124 | 3 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 2.39e-03 | 63 | 124 | 3 | EFO_0022292 | |
| Disease | Global developmental delay | 2.44e-03 | 133 | 124 | 4 | C0557874 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 2.56e-03 | 18 | 124 | 2 | OBA_2045175 | |
| Disease | Bone marrow hypocellularity | 2.56e-03 | 18 | 124 | 2 | C1855710 | |
| Disease | cortical thickness | CCDC91 HTR1D MYCBP2 JMJD1C MEF2C PLEKHM1 SP8 EGFR SH3PXD2A ADAMTS18 CAMTA1 ARHGAP21 | 2.58e-03 | 1113 | 124 | 12 | EFO_0004840 |
| Disease | neutrophil count, basophil count | 2.61e-03 | 224 | 124 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 2.71e-03 | 137 | 124 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | venous thromboembolism, fibrinogen measurement | 2.85e-03 | 67 | 124 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | ovulation | 2.86e-03 | 19 | 124 | 2 | GO_0030728 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.88e-03 | 447 | 124 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | breast size | 3.10e-03 | 69 | 124 | 3 | EFO_0004884 | |
| Disease | iron biomarker measurement, transferrin measurement | 3.17e-03 | 20 | 124 | 2 | EFO_0004461, EFO_0006341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QASLSSCSESSILTA | 341 | O00590 | |
| SGSSASVASTSSIKC | 686 | O60566 | |
| AAVNTGVSTSAACTT | 316 | Q9UMD9 | |
| GVSTSAACTTSVQSD | 321 | Q9UMD9 | |
| SRNSSQSSSDGSCKT | 131 | Q9BSF8 | |
| TVKTEASSQTSSCSG | 646 | Q9Y6Y1 | |
| AQPSSCSISASSTGS | 191 | Q76N32 | |
| CSISASSTGSSLQGH | 196 | Q76N32 | |
| LGQQLEVASTCSSSS | 26 | A8MQ03 | |
| TTSTSALNSLVVSCA | 386 | Q96Q42 | |
| QSLSRSNVASSAACS | 41 | Q16352 | |
| SNVASSAACSSASSL | 46 | Q16352 | |
| CTASNSLTGLARSTS | 416 | Q6UY09 | |
| GASTSNACTLSAIST | 1001 | Q8IWV2 | |
| SETISEGTSNSLSTC | 1676 | O75179 | |
| CTQTGSVVLNSSSES | 1171 | Q8IZT6 | |
| SVDSANTTISACNIS | 1266 | Q9C0F0 | |
| NDSSSSVAVSTCAGL | 151 | Q8TE60 | |
| RQSCISTSASGLDTS | 1526 | Q7Z401 | |
| TSESSCTTIDGLNAT | 346 | P26374 | |
| CSSTNTCALSGLTRT | 296 | Q8TBN0 | |
| VTSACSLQTEGSLST | 351 | O43502 | |
| LGSTSSNSSCSSTEC | 21 | Q9H3Y8 | |
| SSSSQCSVPSLSSLT | 521 | Q8WYB5 | |
| GSLSSSIQSTCQFES | 41 | Q96NW4 | |
| TSSCLFSVHSSLQGS | 371 | Q6NSJ2 | |
| GSLSSSQCSQSLSVS | 551 | Q9NVI1 | |
| EATVGACASSSTQST | 686 | Q9Y561 | |
| TSSVCSPAGINSVSS | 201 | P08235 | |
| TLSSPAASTVGSICS | 321 | P08235 | |
| SLSSSSTSAGCASSL | 441 | Q14774 | |
| LSCGASQSVSSSYLA | 41 | A0A0C4DH25 | |
| KDVALSSGSACTSAS | 371 | Q9Y697 | |
| ANGSSICINSSLNSS | 11 | Q96JK9 | |
| TTCFATSTIGVTTNA | 1941 | Q2M2H8 | |
| QISSSSTGCLSSPNA | 266 | Q9Y6Y0 | |
| TTASTSGSETNTACT | 1456 | E2RYF6 | |
| TTFSSCTISSLQCGT | 246 | Q5VTL7 | |
| IACTQSSARSLVGSS | 656 | O15111 | |
| SSPSSCSLSSQVGLT | 441 | O60333 | |
| SSSNSNETINCSSGS | 701 | Q5JU85 | |
| ASQGSCVASETSTGT | 366 | Q2KJY2 | |
| SNTILASTSSECVSS | 1421 | Q15652 | |
| SNDVTQSCSSGRSTT | 801 | Q6UXG2 | |
| SFCSGVTDSSTQSLA | 351 | Q8WYN3 | |
| STCFVSQSGTSQAAA | 376 | Q8NBP7 | |
| RVTISCSGSSSNIGS | 36 | P01700 | |
| STSSSRCDQGNTAAT | 626 | Q14149 | |
| SSVCSSLNSVNSSDS | 271 | O43312 | |
| TTQSTLTTTAGTCDN | 2946 | Q02505 | |
| RVTISCSGSSSNIGS | 36 | P01699 | |
| TLSSCSQSQTSASTL | 1311 | Q8TDM6 | |
| TTTAATSGFSFCQAS | 1826 | P35658 | |
| SALSQLGACTSTHLS | 361 | Q06413 | |
| LGACTSTHLSQSSNL | 366 | Q06413 | |
| SSGSSNSTDSGICLQ | 361 | Q13651 | |
| VLCSNSSSLGSSTPT | 126 | P50222 | |
| ISASASTSQASICSS | 3061 | Q9Y4D8 | |
| STSQASICSSQGISQ | 3066 | Q9Y4D8 | |
| SSCRTSNSSQTLSSC | 171 | Q96PQ7 | |
| QTLSLTCAISGDSVS | 36 | A0A0B4J1U7 | |
| TCAISGDSVSSNSAA | 41 | A0A0B4J1U7 | |
| NISVSSSTALSVANC | 496 | Q9UPP2 | |
| STATTSCINGRSTAV | 821 | A8MWY0 | |
| CSFGDQTTSATLTVT | 3256 | Q5VST9 | |
| CTCGSQATSATLTVT | 3961 | Q5VST9 | |
| GLSSSSSLTQSSCVV | 1591 | Q92794 | |
| SSLSATSNNSTVACI | 1036 | P00533 | |
| SLSRCSSLSSLSSAG | 1066 | O95996 | |
| CSTSNTSAENLTCLS | 16 | Q6PRD7 | |
| SSVCSVASSSDISLG | 1386 | Q9ULT8 | |
| AGTSTQTQSSCSVPS | 16 | P27352 | |
| STTSCSSSLQSGAVA | 66 | O00716 | |
| IASGSSASAASEAQC | 1576 | O43497 | |
| CESQSNSLVTSTLAS | 186 | P19525 | |
| SSSIGCLSSDAIISS | 56 | Q7Z6B0 | |
| ETSLIGTAACTSTSS | 106 | Q14534 | |
| SCSEAAGVESLSQSS | 96 | Q6PIV2 | |
| SSSSSVAAAAASGQC | 26 | P35453 | |
| TGSAGSSLCSLNSSL | 246 | P28221 | |
| SNACLVTTDQASSGS | 691 | Q6IMN6 | |
| STSNQTLCGEQTTTS | 451 | A0A0U1RQI7 | |
| SNQTLCGEQTTTSTS | 691 | A0A0U1RQI7 | |
| SVSALLASCTLSGSN | 16 | Q8IYD9 | |
| LASCTLSGSNSSNSD | 21 | Q8IYD9 | |
| LESCTSGFSQLSAAT | 666 | O43304 | |
| SCLSSQSSALSQSGG | 31 | Q8IXA5 | |
| TSLCTDTNCASQSTT | 266 | Q9BUN1 | |
| SATCSSATAAASSGL | 431 | Q96G74 | |
| ASDKGSSCSSSRQNL | 121 | Q8NAN2 | |
| ICSTRQGSATGTISS | 1921 | P0C091 | |
| SLSLDTASSSQLSCS | 251 | Q9Y4G2 | |
| TASSSQLSCSLNSDS | 256 | Q9Y4G2 | |
| LASCTSSAASVAAGN | 361 | Q13761 | |
| VSSSQSGCSIASDSG | 186 | Q8TEU7 | |
| NLTLSSSGAIDQSSC | 481 | Q96PX1 | |
| NDTLNGISSSSVCTE | 1146 | Q9UMZ2 | |
| ASVTSLNSSATGRCL | 1151 | P21675 | |
| DVLSCTGTSNSASAN | 656 | Q15788 | |
| SASQSTLLCSSPSNG | 536 | Q96SF7 | |
| CASQIIGSDTSSSGS | 241 | Q9P0U3 | |
| SVSGQQTLCSSSEAS | 441 | Q6PI26 | |
| QATDCSSTTKAASGT | 536 | Q9ULL8 | |
| QGISPCSTLTSSTAS | 171 | Q9C0D5 | |
| EITSATQTSSLCSSG | 6 | Q2M3A8 | |
| FSENLCGLSTSATVT | 341 | Q13203 | |
| VTFTFSTCSLSSNGT | 1856 | O75592 | |
| ANSSSLCTSSNGSLS | 4391 | Q9P2P6 | |
| SSTEVSGALKSTSCS | 851 | P11215 | |
| SALGCLTPSASTSQT | 826 | Q96KW2 | |
| SSENSTSTLSTCLIN | 131 | Q9Y6L6 | |
| KRSSSSCNLGSSLSG | 51 | P0CG40 | |
| SQSCSSGKRLSSADV | 761 | Q9Y2K9 | |
| PTLSAAASATLASSC | 41 | O94993 | |
| SSSSSSASCNVVGSS | 36 | Q8IXZ3 | |
| LSCGSSGSSSSNTAV | 696 | O60296 | |
| STAVNSCSPQSLSSV | 341 | Q5T6F2 | |
| TNLNTCGDSAETAST | 406 | O95497 | |
| SSTGCSRSNQLTFTE | 156 | Q7Z6I5 | |
| IAGLSSISQCTSSSQ | 261 | O95235 | |
| SSASFSSSITINTTC | 686 | Q5TCZ1 | |
| SSSITINTTCCSSSS | 691 | Q5TCZ1 | |
| SGSCSLTNVKASTSN | 1166 | Q6ZQQ2 | |
| AASNIAGCSTSNPTT | 691 | Q5VZP5 | |
| NGLFSTLSSSAICSS | 216 | Q5GFL6 | |
| SVTFSLLVSGSQDCT | 2991 | Q6ZS81 | |
| LCSSDSSASASQVAG | 11 | Q8IYF3 | |
| NSIASFTSICSSQCS | 1116 | Q70Z35 | |
| ANSQTTTANCVSLTT | 741 | Q68DE3 | |
| AAQASAASATLSSCS | 181 | O15492 | |
| CSATNSLGNATSTLD | 491 | Q9BZZ2 | |
| STISNESSQSCSSGR | 701 | Q2NKQ1 | |
| SSGAVTVLSTTCFHS | 761 | O43151 | |
| STCSNESLSVGGTSV | 751 | O60343 | |
| AVDITTGTNSCLSNS | 266 | O15060 | |
| ANNCTVNTSSVATSS | 451 | Q96KR1 | |
| TDATSVCTALISSAS | 986 | Q9Y2L5 | |
| SSAPATCSQSVISSV | 1116 | Q9Y4F4 | |
| TVAAASATTAASSSL | 91 | Q9H7D7 | |
| TASQLCIQLSSSTST | 1501 | Q9H4A3 | |
| SLHCNTGSSSSTLAS | 1891 | Q5T5U3 | |
| SSAGLCNSSSLTENV | 346 | Q9NYI0 | |
| NSTISANSTNADTCT | 251 | Q9H2H9 | |
| ASSSTASSTTSICVC | 1176 | P41229 | |
| SSSLNVASDSIAGCS | 246 | Q86UW6 | |
| SSVSSLCLSNTASSH | 2431 | B2RTY4 |